In fact, besides the well-known prognostic value of this biomarker in HF patients, a recent meta-analysis showed that patients that presented RVF post-implant had the tendency to have higher levels of NT-proBNP, even though high heterogeneity was found among the studies [20]. This evidence concerns the gene NPPB and hydrops fetalis.